PE20091359A1 - Proceso de preparacion de compuestos organicos intermediarios de inhibidores de renina - Google Patents
Proceso de preparacion de compuestos organicos intermediarios de inhibidores de reninaInfo
- Publication number
- PE20091359A1 PE20091359A1 PE2009000932A PE2009000932A PE20091359A1 PE 20091359 A1 PE20091359 A1 PE 20091359A1 PE 2009000932 A PE2009000932 A PE 2009000932A PE 2009000932 A PE2009000932 A PE 2009000932A PE 20091359 A1 PE20091359 A1 PE 20091359A1
- Authority
- PE
- Peru
- Prior art keywords
- preparation
- organic compounds
- renin inhibitors
- alkyl
- intermediary
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
REFERIDA A UN PROCEDIMIENTO PARA LA FABRICACION DE UN COMPUESTO DE FORMULA (IVa) QUE COMPRENDE REMOVER LOS GRUPOS PROTECTORES R2 Y PG DE UN COMPUESTO DE FORMULA (I), DONDE R ES H, ALQUILO C1-C20 O ALCOXIALQUILO C1-C20; R1 ES H, ALQUILO C1-C20, ALCOXIALQUILO C1-C20; R3 ES H O ALQUILO C1-C20; R2 ES H O HIDROXILO; PG ES UN GRUPO PROTECTOR AMINO TAL COMO UN ALCOXICARBONILO C1-C7. DICHOS COMPUESTOS SON UTILES COMO INTERMEDIARIOS EN LA PREPARACION DE COMPUESTOS INHIBIDORES DE RENINA TALES COMO EL ALISCIREN
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0511686.8A GB0511686D0 (en) | 2005-06-08 | 2005-06-08 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20091359A1 true PE20091359A1 (es) | 2009-10-13 |
Family
ID=34835327
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000621A PE20070075A1 (es) | 2005-06-08 | 2006-06-06 | Procedimiento de preparacion para compuestos inhibidores de renina |
PE2009000932A PE20091359A1 (es) | 2005-06-08 | 2006-06-06 | Proceso de preparacion de compuestos organicos intermediarios de inhibidores de renina |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000621A PE20070075A1 (es) | 2005-06-08 | 2006-06-06 | Procedimiento de preparacion para compuestos inhibidores de renina |
Country Status (24)
Country | Link |
---|---|
US (2) | US7767831B2 (es) |
EP (2) | EP2080754A3 (es) |
JP (2) | JP2008542415A (es) |
KR (1) | KR20080014011A (es) |
CN (1) | CN101193860B (es) |
AR (1) | AR054374A1 (es) |
AU (1) | AU2006256938B2 (es) |
BR (1) | BRPI0611919A2 (es) |
CA (1) | CA2608575A1 (es) |
EC (1) | ECSP077986A (es) |
GB (1) | GB0511686D0 (es) |
GT (1) | GT200600208A (es) |
IL (1) | IL187004A0 (es) |
MA (1) | MA29563B1 (es) |
MX (1) | MX2007015418A (es) |
NO (1) | NO20080080L (es) |
NZ (2) | NZ562889A (es) |
PE (2) | PE20070075A1 (es) |
RU (1) | RU2418785C2 (es) |
SG (1) | SG155209A1 (es) |
TN (1) | TNSN07465A1 (es) |
TW (1) | TW200716544A (es) |
WO (1) | WO2006131304A2 (es) |
ZA (1) | ZA200709076B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0521083D0 (en) * | 2005-10-17 | 2005-11-23 | Novartis Ag | Organic compounds |
DE102007049039A1 (de) | 2007-10-11 | 2009-04-16 | Reuter Chemischer Apparatebau Kg | Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung |
EP2062874B1 (en) | 2007-11-20 | 2014-12-17 | KRKA, tovarna zdravil, d.d., Novo mesto | Process and intermediates for the preparation of aliskiren |
WO2009080773A1 (en) * | 2007-12-24 | 2009-07-02 | Dsm Ip Assets B.V. | Convergent synthesis of renin inhibitors and intermediates useful therein |
EP2189442B1 (en) | 2008-11-20 | 2014-10-01 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process and intermediates for the preparation of aliskiren |
KR101755052B1 (ko) * | 2009-08-11 | 2017-07-06 | 노파르티스 아게 | 락톤 및 락탐의 개환 |
US8203005B2 (en) | 2009-10-29 | 2012-06-19 | Carbo Design Llc | Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren |
WO2011098258A1 (en) * | 2010-02-10 | 2011-08-18 | Ratiopharm Gmbh | Salts of aliskiren |
US8703976B2 (en) | 2011-10-02 | 2014-04-22 | Milan Soukup | Manufacturing process for 8-aryloctanoic acids such as Aliskiren |
CN111423325A (zh) * | 2020-04-26 | 2020-07-17 | 江苏凯迪恩医药科技有限公司 | 基于蒽醌类药物的双醋瑞因合成方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4570108A (en) * | 1982-07-06 | 1986-02-11 | Stroede Aake | Protection device for electrical incandescent lamps |
MY119161A (en) | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
US5606078A (en) | 1994-04-18 | 1997-02-25 | Ciba-Geigy Corporation | 3,5-Disubstituted tetrahydrofuran-2-ones |
US5659065A (en) | 1994-04-18 | 1997-08-19 | Novartis Corporation | Alpha-aminoalkanoic acids and reduction products |
CA2121898A1 (en) * | 1994-04-21 | 1995-10-22 | Stephen Hanessian | Synthesis of prototypes for renin inhibitors |
JP2005231999A (ja) * | 2000-03-08 | 2005-09-02 | Banyu Pharmaceut Co Ltd | カルバペネム誘導体の製造方法 |
BR0112362B1 (pt) | 2000-07-05 | 2013-12-31 | Processo para a preparação de octanoil amidas substituídas e compostos intermediários | |
US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
PT1215201E (pt) * | 2000-12-14 | 2007-02-28 | Speedel Pharma Ag | Processo para a preparação de ariloctanoil amidas |
GB0419361D0 (en) * | 2004-08-31 | 2004-10-06 | Novartis Ag | Organic compounds |
-
2005
- 2005-06-08 GB GBGB0511686.8A patent/GB0511686D0/en not_active Ceased
-
2006
- 2006-05-18 GT GT200600208A patent/GT200600208A/es unknown
- 2006-06-06 RU RU2007148226/04A patent/RU2418785C2/ru not_active IP Right Cessation
- 2006-06-06 NZ NZ562889A patent/NZ562889A/en not_active IP Right Cessation
- 2006-06-06 SG SG200905377-8A patent/SG155209A1/en unknown
- 2006-06-06 US US11/916,875 patent/US7767831B2/en not_active Expired - Fee Related
- 2006-06-06 EP EP09005946A patent/EP2080754A3/en not_active Withdrawn
- 2006-06-06 CA CA002608575A patent/CA2608575A1/en not_active Abandoned
- 2006-06-06 WO PCT/EP2006/005370 patent/WO2006131304A2/en active Application Filing
- 2006-06-06 PE PE2006000621A patent/PE20070075A1/es not_active Application Discontinuation
- 2006-06-06 JP JP2008515124A patent/JP2008542415A/ja active Pending
- 2006-06-06 PE PE2009000932A patent/PE20091359A1/es not_active Application Discontinuation
- 2006-06-06 BR BRPI0611919-0A patent/BRPI0611919A2/pt not_active IP Right Cessation
- 2006-06-06 EP EP06754143A patent/EP1896411A2/en not_active Withdrawn
- 2006-06-06 AU AU2006256938A patent/AU2006256938B2/en not_active Ceased
- 2006-06-06 AR ARP060102357A patent/AR054374A1/es not_active Application Discontinuation
- 2006-06-06 KR KR1020077028644A patent/KR20080014011A/ko not_active Application Discontinuation
- 2006-06-06 MX MX2007015418A patent/MX2007015418A/es active IP Right Grant
- 2006-06-06 CN CN2006800202505A patent/CN101193860B/zh not_active Expired - Fee Related
- 2006-06-06 NZ NZ591010A patent/NZ591010A/en not_active IP Right Cessation
- 2006-06-07 TW TW095120194A patent/TW200716544A/zh unknown
-
2007
- 2007-10-22 ZA ZA200709076A patent/ZA200709076B/xx unknown
- 2007-10-29 IL IL187004A patent/IL187004A0/en unknown
- 2007-12-07 TN TNP2007000465A patent/TNSN07465A1/en unknown
- 2007-12-07 EC EC2007007986A patent/ECSP077986A/es unknown
- 2007-12-26 MA MA30506A patent/MA29563B1/fr unknown
-
2008
- 2008-01-04 NO NO20080080A patent/NO20080080L/no not_active Application Discontinuation
-
2010
- 2010-06-25 US US12/823,518 patent/US20100274027A1/en not_active Abandoned
-
2012
- 2012-08-07 JP JP2012175078A patent/JP2013028607A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20091359A1 (es) | Proceso de preparacion de compuestos organicos intermediarios de inhibidores de renina | |
ES2530991T3 (es) | Procedimiento para la obtención de betamiméticos | |
ECSP10010405A (es) | Procesos e intermediarios para la preparacion de derivados de acido 5-bifenil-4-il-2-metilpentanoico | |
UA109883C2 (uk) | Спосіб отримання сполук для застосування як інгібіторів sglt2 | |
MX2009003834A (es) | Derivados de pirrolidina como inhibidores de iap. | |
GT200500223A (es) | Polimorfo ii de rapamicina y sus utilizaciones | |
PA8676301A1 (es) | Metodos para sintetizar derivados de 6-alquilaminoquinolina | |
CL2019002919A1 (es) | Compuestos inhibidores vmat2 y composiciones relacionadas. | |
EA201190099A1 (ru) | (1-фенил-2-пиридин-4-ил)этиловые эфиры бензойной кислоты в качестве ингибиторов фосфодиэстеразы | |
MY150596A (en) | Hsp90 inhibitors | |
UA108378C2 (uk) | Спосіб одержання плеуромутилінів | |
ECSP11010830A (es) | Derivados de heteroarilo como inhibidores de dgat1 | |
PE20060583A1 (es) | Tiazolil-dihidro-indazoles como inhibidores de pi3-quinasas | |
NI201000049A (es) | Método para producir 2'-desoxi-5-azacitidina (decitabina) | |
UY32077A (es) | Inhibidores de quinasa tipo polo | |
BR112019005294A2 (pt) | processo para preparar (±)-2-exo-(2-metilbenzilóxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano de fórmula (i) e método para prevenir ou reduzir a formação de depósitos no interior de um reator | |
AR108558A2 (es) | Método para preparar ácido (+)-1,4-dihidro-7-[(3s,4s)-3-metoxi-4-(metilamino)-1-pirrolidinil]-4-oxo-1-(2-tiazolil)-1,8-naftiridin-3-carboxílico | |
EA201290872A1 (ru) | Способ получения бензоксаборолов | |
EA200970266A1 (ru) | Азабициклические соединения в качестве ингибиторов повторного поглощения моноаминов | |
ECSP099315A (es) | Inhibidores de cinasa | |
TNSN06260A1 (en) | Process for the preparation of tryptase inhibitors | |
PE20070526A1 (es) | Metodos para preparar derivados de acido glutamico | |
WO2010002528A3 (en) | Hydrofluoroacetal compounds and processes for their preparation and use | |
AR059546A1 (es) | Derivados de cromen -2-ona utiles como inhibidores de recaptacion del neurotransmisor de monoamina | |
NI201100035A (es) | Agentes antifúngicos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |